CLINICAL TRIALS PROFILE FOR FLECTOR
✉ Email this page to a colleague
All Clinical Trials for FLECTOR
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01054820 ↗ | Study to Assess the Effectiveness and Safety of FLECTOR Patch for Treatment of Acute Back Strain | Completed | Pfizer | Phase 4 | 2010-01-01 | Although approved for minor strains, sprains and contusions, FLECTOR Patch has not been studied extensively in the setting of acute back strain. This study is being conducted as an initial step in demonstrating the benefit of FLECTOR Patch specifically for back strain. In particular, this study is expected to provide information about the amount of improvement in back strain among subjects using the FLECTOR Patch, which may then be used to inform subsequent studies. |
| NCT02132247 ↗ | Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries | Completed | IBSA Institut Biochimique SA | Phase 4 | 2014-05-01 | The primary purpose of this study is to determine whether Flector Patch is safe for use in children. The secondary purpose is to assess blood levels of diclofenac, the active ingredient in Flector Patch. |
| NCT02324270 ↗ | Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain | Completed | Actavis Inc. | Phase 3 | 2014-05-01 | To demonstrate the therapeutic efficacy of a generic diclofenac epolamine patch against Flector patch in the treatment of pain in subjects with minor ankle sprain |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FLECTOR
Condition Name
Clinical Trial Locations for FLECTOR
Trials by Country
Clinical Trial Progress for FLECTOR
Clinical Trial Phase
Clinical Trial Sponsors for FLECTOR
Sponsor Name
